
Researchers find 1 lipid class and 6 miRNAs differed significantly between different treatment groups.

Researchers find 1 lipid class and 6 miRNAs differed significantly between different treatment groups.

It is possible to diagnose patients with ADHD as young as 2 years old.

AXS-05 significantly relieved agitation, demonstrating a change from baseline in the CMAI total score of 15.4 compared to 11.5 for the placebo.

Less than 2% of surveyed families with rheumatic-disease children had reported a COVID-19 case in the early pandemic—and even fewer had physician-confirmed symptoms.

Treatment for ADHD is similar for adolescents and adult patients.

Dr. David Goodman will present 5 times during NEI about different ADHD issues and topics.

In the study, investigators tested the impact of the study drug in a rerandomized patient population that previously received a placebo.

A discussion on how the pandemic has burdened and, in some ways, bettered the very involved specialty.

A large portion of communication is non-verbal.

Clinicians rated 82% of the patients receiving the study drug and 46% in the placebo group as either much improved or very much improved on the Clinical Global Impression of Improvement scale.

Both methylphenidate PRC-063 and lisdexamfetamine led to improved performances for drivers with ADHD.

In new data presented at ACG 2020, investigators report on the clinical characteristics and outcomes of chronic pancreatitis patients with CDI.

Rifaximin and lactulose did not result in clinically relevant changes to fecal microbial antibiotic susceptibility profiles.

Up to 91% of the gastroenterologist respondents plan to integrate telehealth into their practice following the COVID-19 pandemic.

In data presented at ACG 2020, researchers show a combination of sulindac and eflornithine could be effective for FAP patients.

Data suggests a more scrutinized follow-up period following surgery.

A new ACG study shows that 18% would have been considered low risk for NASH-F based on FAST score despite having high liver stiffness measurement.

Researchers examine he prevalence of and factors influencing EPI treatment with PERT in pancreatic cancer.

Girish Hiremath, MD, MPH, discusses a need to more accurately and objectively assess pediatric compliance to eosinophilic esophagitis therapies.

The CDC has standardized guidelines to help diagnose diarrhea, a potential indicator of c. difficile infection.

Female gender, Caucasian race, and older age were all significantly associated with microscopic colitis.

Experts recommend closer follow-up after the surgical removal of pancreatic cysts.

Benjamin Noor, MD, discusses a recent study from ACG that demonstrated that EBTs are associated with improved parameters for weight loss and diabetes.

Tunneled catheters resulted in lower rates of deep vein thrombosis when compared to PICCs.

The findings also showed that large bedded hospitals trended towards higher clostridium difficile infection incidence and mortality rates.

Over the course of the 19 year review, biologic use has increased, while the prevalence of colectomies has decreased.

A new study demonstrates that vedolizumab is associated with real-world corticosteroid-free response and remission in patients with ulcerative colitis and Crohn’s disease.

In a study presented at ACG, investigators find the rate of confirmed HCV infections remained stable pre- and post-interventions.

Brooks Cash, MD, discusses the importance of bowel preparation and surveillance in patients with diabetes.